Q: Can we start with some insights as to why the Local Affiliate Services solution was established and what its overarching objectives are? A: There …
Increasing adoption of digital trials and data-driven commercial strategies has laid the foundations for improved pinpointing of treatments and speedier diagnoses. Though estimates show that …
Highly potent drugs are becoming increasingly common in the drug development pipeline. The focus on oncology, rare diseases, and targeted therapies is growing even more acute. While …
Q: Can we start with a brief history of PharmaLex, what are your key offerings into the industry? A: PharmaLex was established 25 years ago …
Oral solid dose (OSD) forms have accounted for the lion’s share of the pharmaceutical market for decades, thanks to their easy administration leading to patient …
From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables Life Science …
The market for parenteral drug-device combination products has evolved rapidly over the last 15–20 years and is expected to grow at a CAGR of 24.3% …
Kindeva Drug Delivery is a contract development and manufacturing organisation (CDMO) specialising in complex drug formulation and delivery. Seeking to scale its production of coated …
New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market PHILADELPHIA – July 27, 2022 – PCI Pharma Services …
The market for parenteral drug-device combination products has been evolving over the last 15–20 years, developing innovation both on formulation and device design fronts. The …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
